Please login to order a test.
Drug Screen, With Medication Report, Whole Blood
Acetaminophen; amphetamines; barbiturates; benzodiazepines; buprenorphine; carisoprodol; cocaine metabolite; ethyl alcohol; fentanyl; gabapentin; meperidine; methadone; opiates; oxycodones; phencyclidine (PCP); propoxyphene; tetrahydrocannabinol (THC); tramadol; other drugs detected
This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA).
Initial presumptive testing by immunoassay at the following testing thresholds: amphetamines, 50 ng/mL; barbiturates, 0.1 μg/mL; benzodiazepines, 20 ng/mL; buprenorphine, 1.0 ng/mL; carisoprodol, 0.5 μg/mL; cocaine metabolite, 25 ng/mL; fentanyl, 1.0 ng/mL; gabapentin, 1.0 μg/mL; methadone, 25 ng/mL; meperidine, 100 ng/mL; opiates, 5 ng/mL; oxycodones, 5 ng/mL; phencyclidine (PCP), 8 ng/mL; propoxyphene, 50 ng/mL; tetrahydrocannabinol (THC), 5 ng/mL; tramadol, 50 ng/mL; presumptive positives confirmed to limit of quantitation by definitive chromatography mass spectrometry (GC/MS or LC/MS-MS). Initial presumptive testing by immunoassay for acetaminophen at a testing threshold of 5.0 µg/mL; presumptive positives quantitated by immunoassay. Initial presumptive testing for ethanol by enzymatic assay at a testing threshold of 0.020 gm/dL; presumptive positives confirmed by gas chromatography (GC). Other drugs are detected by full scan gas chromatography/mass spectrometry (GC/MS).
Submission/transport (<3 days): Room temperature. For storage beyond three days, specimen should be refrigerated or frozen.